» Articles » PMID: 27167072

Epigenetic Alterations of CYP19A1 Gene in Cumulus Cells and Its Relevance to Infertility in Endometriosis

Overview
Publisher Springer
Date 2016 May 12
PMID 27167072
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of the present study was to investigate the epigenetic mechanisms responsible for the aberrant aromatase expression (CYP19A1) in Cumulus Cells (CCs) of infertile endometriosis patients.

Method: Cumulus cells were obtained from 24 infertile patients with and without endometriosis who underwent ovarian stimulation for intracytoplasmic sperm injection. Expression of CYP19A1 gene was quantified using Reverse Transcription Q-PCR. DNA methylation, histone modifications, and binding of Estrogen Receptor, ERβ to regulatory DNA sequences of CYP19A1 gene were evaluated by Chromatin ImmunoPrecipitation (ChIP) assay.

Results: CYP19A1 gene expression in CCs of endometriosis patients was significantly lower than the control group (P = 0.04). Higher incorporation of MeCP2 (as a marker of DNA methylation) on PII and PI.4 promoters, and hypoacetylation at H3K9 in PII and hypermethylation at H3K9 in PI.4 were observed in CYP19A1 gene in endometriosis patients (P < 0.05). Moreover, a decreased level of ERβ binding to PII and an increased level of its binding to PI.3 and PI.4 promoters of CYP19A1 were observed in endometriosis patients when compared to control.

Conclusion: Significant reduction of CYP19A1 gene expression in CCs of endometriosis patients may be the result of epigenetic alterations in its regulatory regions, either by DNA methylation or histone modifications. These epigenetic changes along with differential binding of ERβ (as a transcription factor) in CYP19A1 promoters may impair follicular steroidogenesis, leading to poor Oocyte and embryo condition in endometriosis patients.

Citing Articles

Role of Epigenetic Modification in the Intergeneration Transmission of War Trauma.

Bolouki A Indian J Clin Biochem. 2024; 39(3):312-321.

PMID: 39005862 PMC: 11239641. DOI: 10.1007/s12291-023-01136-1.


The Known, the Unknown and the Future of the Pathophysiology of Endometriosis.

Ochoa Bernal M, Fazleabas A Int J Mol Sci. 2024; 25(11).

PMID: 38892003 PMC: 11172035. DOI: 10.3390/ijms25115815.


A Systematic Review of Epigenetics of Endometriosis.

Bedrick B, Courtright L, Zhang J, Snow M, Amendola I, Nylander E F S Rev. 2024; 5(1).

PMID: 38524912 PMC: 10956470. DOI: 10.1016/j.xfnr.2024.01.003.


Abnormal DNA methylation within genes of the steroidogenesis pathway two years after paediatric critical illness and association with stunted growth in height further in time.

Vanhorebeek I, Coppens G, Guiza F, Derese I, Wouters P, Joosten K Clin Epigenetics. 2023; 15(1):116.

PMID: 37468957 PMC: 10354984. DOI: 10.1186/s13148-023-01530-9.


Paternal genetic effects of cadmium exposure during pregnancy on hormone synthesis disorders in ovarian granulosa cells of offspring.

Sun Y, Liu Z, Zhang W, Lin H, Li Q, Liu C J Ovarian Res. 2023; 16(1):98.

PMID: 37194017 PMC: 10186638. DOI: 10.1186/s13048-023-01175-5.


References
1.
Adashi E, Hsueh A . Estrogens augment the stimulation of ovarian aromatase activity by follicle-stimulating hormone in cultured rat granulosa cells. J Biol Chem. 1982; 257(11):6077-83. View

2.
Pellicer A, Navarro J, Bosch E, Garrido N, Garcia-Velasco J, Remohi J . Endometrial quality in infertile women with endometriosis. Ann N Y Acad Sci. 2001; 943:122-30. DOI: 10.1111/j.1749-6632.2001.tb03796.x. View

3.
Fuks F, Hurd P, Wolf D, Nan X, Bird A, Kouzarides T . The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem. 2002; 278(6):4035-40. DOI: 10.1074/jbc.M210256200. View

4.
Bulun S, Monsivais D, Kakinuma T, Furukawa Y, Bernardi L, Pavone M . Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med. 2015; 33(3):220-4. DOI: 10.1055/s-0035-1554053. View

5.
Tesarik J, Mendoza C . Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab. 1995; 80(4):1438-43. DOI: 10.1210/jcem.80.4.7714121. View